Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)

被引：0
|
作者：
Chaibi, P [1 ]
Dombret, H [1 ]
Rousselot, P [1 ]
Gardin, C [1 ]
Glaisner, S [1 ]
Castaigne, S [1 ]
Degos, L [1 ]
机构：
[1] HOP ST LOUIS,SERV CLIN MALAD SANG,PARIS,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：822 / 822
页数：1
相关论文
共 50 条
  • [31] FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk acute myeloid leukemia and myelodysplastic syndromes
    Montesinos, Pau
    de la Rubia, Javier
    Orti, Guillermo
    Sanz, Jaime
    Martinez, David
    Mendoza, Ninotchka
    Scaff, Miguel
    Paciello, Mariliz
    Romero, Monica
    Martin, Guillermo
    Lorenzo, Ignacio
    Martinez, Jesus
    Algarra, Lorenzo
    Jarque, Isidro
    Perez-Sirvent, Mariluz
    Sanz, Guillermo
    Sanz, Miguel A.
    BLOOD, 2007, 110 (11) : 843A - 843A
  • [32] Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon
    Latagliata, R
    Bongarzoni, V
    Carmosino, I
    Mengarelli, A
    Breccia, M
    Borza, PA
    D'Andrea, M
    D'Elia, GM
    Mecarocci, S
    Morano, SG
    Petti, MC
    Mandelli, F
    Alimena, G
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 281 - 285
  • [33] Treatment with homoharringtonine and cytarabine in patients with high risk acute myelogenous leukemia (AML).
    Chang, Naibai
    Wei, Jianping
    Zhao, Shengming
    Liu, Hui
    Fan, Yun
    Li, Jiangtao
    Xu, Xiaodong
    Gu, Xichun
    BLOOD, 2006, 108 (11) : 218B - 218B
  • [34] Individualized intensive chemotherapy for elderly patients age over 65 with acute myelogenous leukemia
    Saitou, Y
    Uzuka, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 22 - 23
  • [35] Homoharringtonine, cytarabine and cyclopbosphamide in patients with acute myelogenous leukemia for induction chemotherapy
    Qiao, ZH
    Su, LP
    Jia, HF
    Liu, GJ
    Pei, YH
    BLOOD, 2002, 100 (11) : 259B - 259B
  • [36] Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia
    Xueya Zhang
    Xizhe Guo
    Annals of Hematology, 2019, 98 : 2223 - 2225
  • [37] Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)
    Fridle, Chantal
    Medinger, Michael
    Wilk, Matthias C.
    Seipel, Katja
    Passweg, Jakob
    Manz, Markus G.
    Pabst, Thomas
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1068 - 1075
  • [38] Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia
    Zhang, Xueya
    Guo, Xizhe
    ANNALS OF HEMATOLOGY, 2019, 98 (09) : 2223 - 2225
  • [39] Induction of acute myeloid leukemia (AML) with idarubicin, cytarabine and cladribine (ICC).
    Wiedower, Eric
    Jamy, Omer Hassan
    Martin, Michael Gary
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA
    GALE, RP
    FOON, KA
    CLINE, MJ
    ZIGHELBOIM, J
    ANNALS OF INTERNAL MEDICINE, 1981, 94 (06) : 753 - 757
12345